These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 29925074

  • 1. A Retrospective Study of Letrozole Treatment Prior to Human Chorionic Gonadotropin in Women with Polycystic Ovary Syndrome Undergoing In Vitro Fertilization at Risk of Ovarian Hyperstimulation Syndrome.
    Chen Y, Yang T, Hao C, Zhao J.
    Med Sci Monit; 2018 Jun 20; 24():4248-4253. PubMed ID: 29925074
    [Abstract] [Full Text] [Related]

  • 2. Mild ovarian stimulation with letrozole plus fixed dose human menopausal gonadotropin prior to IVF/ICSI for infertile non-obese women with polycystic ovarian syndrome being pre-treated with metformin: a pilot study.
    D'Amato G, Caringella AM, Stanziano A, Cantatore C, Palini S, Caroppo E.
    Reprod Biol Endocrinol; 2018 Sep 14; 16(1):89. PubMed ID: 30217209
    [Abstract] [Full Text] [Related]

  • 3. [Clinical analysis of assistant treatment proposals for infertile women with polycystic ovary syndrome].
    Chen ZJ, Shi YH, Li Y, Gao Q, Sheng Y, Ma ZX.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Aug 14; 43(8):571-5. PubMed ID: 19087489
    [Abstract] [Full Text] [Related]

  • 4. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
    Yu R, Lin J, Zhao JZ, Wang PY, Xiao SQ, Zhang W.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr 14; 47(4):250-4. PubMed ID: 22781109
    [Abstract] [Full Text] [Related]

  • 5. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
    Xiao ZN, Peng JL, Yang J, Xu WM.
    Curr Med Sci; 2019 Jun 14; 39(3):431-436. PubMed ID: 31209815
    [Abstract] [Full Text] [Related]

  • 6. [Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome].
    Li X, Ding W, Liu JY, Mao YD, Huang J, Wang W, Ma X.
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun 25; 53(6):402-408. PubMed ID: 29961283
    [Abstract] [Full Text] [Related]

  • 7. Application value of tumor necrosis factor inhibitors in in vitro fertilization-embryo transfer in infertile women with polycystic ovary syndrome.
    Liang JX, Zhang Y, Xiao CH, Cao S, Tian Y, Wang NN, Liu C.
    BMC Pregnancy Childbirth; 2023 Apr 13; 23(1):247. PubMed ID: 37055769
    [Abstract] [Full Text] [Related]

  • 8. Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.
    Kamath MS, Maheshwari A, Bhattacharya S, Lor KY, Gibreel A.
    Cochrane Database Syst Rev; 2017 Nov 02; 11(11):CD008528. PubMed ID: 29096046
    [Abstract] [Full Text] [Related]

  • 9. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.
    Kadoura S, Alhalabi M, Nattouf AH.
    Sci Rep; 2022 Mar 15; 12(1):4456. PubMed ID: 35292717
    [Abstract] [Full Text] [Related]

  • 10. Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial.
    Mai Q, Hu X, Yang G, Luo Y, Huang K, Yuan Y, Zhou C.
    Am J Obstet Gynecol; 2017 Jan 15; 216(1):42.e1-42.e10. PubMed ID: 27555316
    [Abstract] [Full Text] [Related]

  • 11. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.
    Youssef MA, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, Aboulfoutouh I, van Wely M.
    Cochrane Database Syst Rev; 2014 Oct 31; 2014(10):CD008046. PubMed ID: 25358904
    [Abstract] [Full Text] [Related]

  • 12. In vitro maturation without gonadotropins versus in vitro fertilization with hyperstimulation in women with polycystic ovary syndrome: a non-inferiority randomized controlled trial.
    Zheng X, Guo W, Zeng L, Zheng D, Yang S, Xu Y, Wang L, Wang R, Mol BW, Li R, Qiao J.
    Hum Reprod; 2022 Jan 28; 37(2):242-253. PubMed ID: 34849920
    [Abstract] [Full Text] [Related]

  • 13. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome.
    Das M, Son WY, Buckett W, Tulandi T, Holzer H.
    Reprod Biomed Online; 2014 Nov 28; 29(5):545-51. PubMed ID: 25262236
    [Abstract] [Full Text] [Related]

  • 14. Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study.
    Xi W, Liu S, Mao H, Yang Y, Xue X, Lu X.
    Drug Des Devel Ther; 2015 Nov 28; 9():6001-8. PubMed ID: 26648691
    [Abstract] [Full Text] [Related]

  • 15. Aromatase inhibitors for subfertile women with polycystic ovary syndrome.
    Franik S, Kremer JA, Nelen WL, Farquhar C.
    Cochrane Database Syst Rev; 2014 Feb 24; (2):CD010287. PubMed ID: 24563180
    [Abstract] [Full Text] [Related]

  • 16. Comparison of IVF/ICSI outcome in patients with polycystic ovarian syndrome or tubal factor infertility.
    Okohue JE, Onuh SO, Ikimalo JI.
    Niger J Clin Pract; 2013 Feb 24; 16(2):207-10. PubMed ID: 23563463
    [Abstract] [Full Text] [Related]

  • 17. [Optimal Ovulation Induction in Polycystic Ovary Syndrome Resistant to Clomiphene Citrate or Letrozole.].
    Chen Y, Zhang D.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov 24; 47(6):874-877. PubMed ID: 28598116
    [Abstract] [Full Text] [Related]

  • 18. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M, Bogstad J, Bryndorf T, Løssl K, Roskær J, Holland T, Prætorius L, Zedeler A, Nilas L, Pinborg A.
    Hum Reprod; 2016 Jun 24; 31(6):1253-64. PubMed ID: 27060174
    [Abstract] [Full Text] [Related]

  • 19. Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial.
    Wang Y, Chen Q, Wang N, Chen H, Lyu Q, Kuang Y.
    Medicine (Baltimore); 2016 Mar 24; 95(9):e2939. PubMed ID: 26945402
    [Abstract] [Full Text] [Related]

  • 20. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T, Ellenbogen A, Michaeli M, Kartchovsky E, Ruzov O, Shalom-Paz E.
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug 24; 179():46-50. PubMed ID: 24965979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.